Nikhil Prasad Fact checked by:Thailand Medical News Team Dec 23, 2024 4 hours, 6 minutes ago
Medical News: A recent study has unveiled the complex role of Toll-like receptor 7 (TLR7) in the progression of influenza A virus (IAV) infections, particularly its dual impact on lung health. The research, conducted by scientists from RMIT University in Melbourne, Australia, the University of South Australia in Adelaide, and Trinity College Dublin in Ireland, sheds light on how TLR7’s activity can both worsen and alleviate symptoms of IAV infections at different stages. This
Medical News report will explore the findings of this study, which aims to advance our understanding of immune responses to influenza and inform potential therapeutic strategies.
Murine Study Reveals Dual Role of TLR7 in Influenza A Infection
Influenza A infects approximately one billion people worldwide annually, with severe respiratory complications in millions of cases. The study focuses on the role of TLR7, a receptor that recognizes viral RNA, in regulating lung inflammation and airway functionality during IAV infections. Using both wild-type and TLR7-deficient mice, researchers investigated TLR7’s role in acute infection and the subsequent recovery phases.
Key Findings of the Study
-TLR7’s Role in Acute Inflammation
The study revealed that during the peak of IAV infection, TLR7 significantly contributed to acute lung dysfunction by amplifying inflammation. Infected wild-type mice experienced severe airway resistance and elastance - measures of lung stiffness and airflow obstruction - at seven days post-infection. These changes were accompanied by heightened recruitment of neutrophils and monocytes to the lungs, which were strongly correlated with impaired respiratory function.
By contrast, TLR7-deficient mice displayed reduced lung inflammation and milder airway dysfunction during this acute phase. This suggests that the inflammatory response mediated by TLR7 is a critical driver of lung damage in the early stages of infection.
-Delayed Hyperresponsiveness in TLR7-Deficient Mice
Interestingly, the absence of TLR7 delayed the onset of airway hyperresponsiveness, a hallmark of respiratory complications. By the 14th day of infection, TLR7-deficient mice exhibited increased airway reactivity and stiffness, contrasting with the recovery observed in wild-type mice. This late-stage dysfunction was associated with elevated levels of eosinophils - immune cells linked to allergic inflammation - and a skewed Th2-type immune response in TLR7-deficient mice. These findings highlight a dual role of TLR7: exacerbating acute inflammation but also preventing chronic airway dysfunction by suppressing Th2-mediated responses.
-Immune Dynamics in the Lung
The recruitment and activation of immune cells in the lung were central to the observed effects of TLR7. Wild-type mice showed a robust influx of neutrophils, monocytes, and T cells during the acute phase, which contributed to significant lung damage. TLR7-deficient mice, on the other hand, exhibited reduced recruitment of these cells initially, resulting in less tis
sue damage. However, by the recovery phase, these mice showed increased levels of eosinophils and monocytes, along with altered cytokine profiles indicative of a Th2-dominated immune response.
For example, interleukin-5 (IL-5), a cytokine that promotes eosinophil recruitment, was significantly elevated in TLR7-deficient mice. This cytokine shift may have driven the delayed airway hyperresponsiveness observed in these mice. Moreover, reduced levels of regulatory T cells (Tregs) and natural killer (NK) cells in TLR7-deficient mice during the recovery phase suggest a lack of immune regulation, further exacerbating chronic airway dysfunction.
Implications for Therapeutic Strategies
The dual role of TLR7 in influenza infection underscores the complexity of immune responses and the need for stage-specific interventions. Early in the infection, TLR7 antagonists could potentially reduce lung inflammation and prevent acute respiratory distress. However, prolonged suppression of TLR7 activity might lead to an unchecked Th2 response, resulting in chronic airway hyperresponsiveness and allergic-like symptoms.
Conversely, TLR7 agonists might be beneficial during the recovery phase to mitigate Th2-driven inflammation and restore immune balance. These findings suggest that tailored therapies targeting TLR7 at specific stages of infection could minimize respiratory complications without compromising overall immunity.
Conclusions
This study provides critical insights into the nuanced role of TLR7 in influenza A infections. While TLR7 contributes to acute inflammation and lung damage, it also plays a protective role in preventing late-stage airway hyperresponsiveness. These findings emphasize the need for a balanced approach when targeting immune pathways in infectious diseases.
The study findings were published in the peer-reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/25/24/13699
For the latest Influenza News, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/ubiquitin-proteasome-system-as-a-new-target-to-fight-influenza-a-virus
https://www.thailandmedical.news/news/metformin-as-a-potential-antiviral
https://www.thailandmedical.news/news/eucalyptus-extract-shows-promise-against-coronaviruses-and-influenza-viruses
https://www.thailandmedical.news/articles/influenza-or-flu
Share
Tweet
Share
